These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10746908)

  • 21. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
    Lecardeur L; Meunier-Cussac S; Dollfus S
    Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predictive value of psychopathological subclassifications for the neuroleptic treatment outcome in schizophrenia.
    Jarema M; Kacperczyk J; Kruszynski S
    Psychopathology; 1991; 24(3):141-6. PubMed ID: 1684443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward a better identification and treatment of schizophrenia prodrome.
    Bota RG; Sagduyu K; Filin EE; Bota DA; Munro S
    Bull Menninger Clin; 2008; 72(3):210-27. PubMed ID: 18990056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A qualitative research study of the evolution of symptoms in individuals identified as prodromal to psychosis.
    Corcoran C; Davidson L; Sills-Shahar R; Nickou C; Malaspina D; Miller T; McGlashan T
    Psychiatr Q; 2003; 74(4):313-32. PubMed ID: 14686457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prodromal symptoms of schizophrenia.
    Hopkins RS
    Br J Psychiatry; 1994 Aug; 165(2):268-9. PubMed ID: 7953045
    [No Abstract]   [Full Text] [Related]  

  • 26. [Prodromes of schizophrenia recurrence].
    Bottai T; Cotton I; Drigeard A; Vaglio V
    Encephale; 2009 Jan; 35 Suppl 1():S33-40. PubMed ID: 19268166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective observations of emerging psychosis.
    Rosen JL; Woods SW; Miller TJ; McGlashan TH
    J Nerv Ment Dis; 2002 Mar; 190(3):133-41. PubMed ID: 11923647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diagnosis of schizophrenia: a review of onset and duration issues.
    Keith SJ; Matthews SM
    Schizophr Bull; 1991; 17(1):51-67. PubMed ID: 2047789
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relapse prevention in first-episode schizophrenia--maintenance vs intermittent drug treatment with prodrome-based early intervention: results of a randomized controlled trial within the German Research Network on Schizophrenia.
    Gaebel W; Riesbeck M; Wölwer W; Klimke A; Eickhoff M; von Wilmsdorff M; Lemke M; Heuser I; Maier W; Huff W; Schmitt A; Sauer H; Riedel M; Klingberg S; Köpcke W; Ohmann C; Möller HJ;
    J Clin Psychiatry; 2011 Feb; 72(2):205-18. PubMed ID: 20673559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnosis and assessment of individuals prodromal for schizophrenic psychosis.
    Addington J
    CNS Spectr; 2004 Aug; 9(8):588-94. PubMed ID: 15273651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schizotypal disorder.
    Battaglia M; Bellodi L
    Hosp Community Psychiatry; 1992 Jan; 43(1):82-3. PubMed ID: 1544660
    [No Abstract]   [Full Text] [Related]  

  • 33. [Elements for understanding "schizophrenic vulnerability"].
    Cousineau P; Sidoun P
    Can J Psychiatry; 1993 Jun; 38(5):327-32. PubMed ID: 8348472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prodromal symptoms and prevention of relapse in schizophrenia.
    Herz M
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):22-5. PubMed ID: 2865253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor-structure of the Italian version of the Scale Of Prodromal Symptoms (SOPS): a comparison with the English version.
    Comparelli A; Savoja V; Kotzalidis GD; Woods SW; Mosticoni S; Vassallo F; Soscia F; Piccione R; Palma G; Pucci D; Girardi P; Conti L; Tatarelli R
    Epidemiol Psychiatr Sci; 2011 Mar; 20(1):45-54. PubMed ID: 21657115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early intervention for schizophrenia: the risk-benefit ratio of antipsychotic treatment in the prodromal phase.
    Weiser M
    Am J Psychiatry; 2011 Aug; 168(8):761-3. PubMed ID: 21813489
    [No Abstract]   [Full Text] [Related]  

  • 37. The assessment of "prodromal schizophrenia": unresolved issues and future directions.
    Lencz T; Smith CW; Auther AM; Correll CU; Cornblatt BA
    Schizophr Bull; 2003; 29(4):717-28. PubMed ID: 14989409
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia.
    Mittal VA; Neumann C; Saczawa M; Walker EF
    Arch Gen Psychiatry; 2008 Feb; 65(2):165-71. PubMed ID: 18250254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [How far is psychopathology still meaningful for the treatment of schizophrenia?].
    Huber G
    Fortschr Neurol Psychiatr; 2001 Sep; 69 Suppl 2():S86-91. PubMed ID: 11533856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
    Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.